-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2017 to Q2 2024.
- Dianthus Therapeutics, Inc. /DE/ Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$17.6M, a 58.1% decline year-over-year.
- Dianthus Therapeutics, Inc. /DE/ Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$56.7M, a 56.9% decline year-over-year.
- Dianthus Therapeutics, Inc. /DE/ annual Net Income (Loss) Attributable to Parent for 2023 was -$43.6M, a 53% decline from 2022.
- Dianthus Therapeutics, Inc. /DE/ annual Net Income (Loss) Attributable to Parent for 2022 was -$28.5M, a 117% decline from 2021.
- Dianthus Therapeutics, Inc. /DE/ annual Net Income (Loss) Attributable to Parent for 2021 was -$13.1M, a 82.5% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)